Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |